Kolexia
Mornex Francoise Radio-thérapie
Mornex Francoise
Radio-thérapie
Hôpital Lyon Sud
Pierre-Bénite, France
250 Activités
768 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinomes Carcinome hépatocellulaire Carcinome pulmonaire non à petites cellules Métastase tumorale Tumeurs du foie Carcinome pulmonaire à petites cellules Lésions radiques Adénocarcinome

Collaborateurs

Voir plus
Girard Nicolas
Girard Nicolas
Clcc Institut Curie, Paris, France
Merle Philippe
Merle Philippe
Hôpital La Croix-Rousse, Lyon, France
Giraud Philippe
Giraud Philippe
Hôpital Européen Georges Pompidou, Paris, France
Azria David
Azria David
Icm Montpellier, Montpellier, France

Industries

Voir plus
AstraZeneca
8 collaboration(s)
Dernière en 2022
Amgen
2 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy
Essai Clinique (AstraZeneca)   19 janvier 2024
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer   04 octobre 2023
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer   18 août 2023
Cancer : retrouver la joie de vivre - Paris Match
Paris Match   25 juin 2023
Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   05 mai 2023
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   21 février 2023
TACE and conformal radiotherapy . TACE alone for hepatocellular carcinoma: A randomised controlled trial.
JHEP reports : innovation in hepatology   29 janvier 2023
58O Real-world overall survival (OS) with durvalumab (D) after chemoradiotherapy (CRT) in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC): Interim analysis from the PACIFIC-R study
Abstract Book of the ESMO Immuno-Oncology Congress 2022 7-9 December 2022   01 décembre 2022
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients: Multicenter Prospective Evaluation of a Predictive Test of Late Toxicities After Radiotherapy by the Rate of Radiation Induced CD8 T-Lymphocyte Apoptosis: Application to Breast and Prostate Cancers.
Essai Clinique (Institut du Cancer de Montpellier)   29 novembre 2022
Surgical resection versus transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]   28 novembre 2022